Insights

Referenced briefings.

Briefings on AI in healthcare and pharma, grounded in peer-reviewed trials, regulatory data and primary sources. Every claim is cited.

Markets15 October 2026

Norrsken VC leads $20M Series A in Vocca's AI phone assistant for medical practices

Vocca says 15,000 practitioners now use its call-handling system, up from 2,000 a year ago, and plans a deeper push into the United States.

Read the briefing

Earlier briefings

October 2026

September 2026

30 SepAI-designed drug for lung fibrosis passes phase 2a and enters phase 3Rentosertib, discovered and designed with Insilico Medicine's generative AI, improved lung function against placebo in a 71-patient trial. A 320-patient phase 3 began in China in September 2026.Pharma
30 SepUCSF model predicts Alzheimer's from health records up to seven years aheadRandom forest models trained on 749 patients with Alzheimer's and 250,545 controls reached an AUROC of 0.72 seven years before onset and 0.81 one day before.Healthcare
30 SepAbbott completes $21 billion purchase of Exact SciencesExact Sciences shareholders received $105 a share. Abbott expects the cancer-screening business to dilute 2026 earnings by $0.20 while lifting growth.Markets
30 SepEAGLE AI model detects oesophageal cancer on routine chest CT with 90.0% sensitivityValidated on 80,612 patients at 12 centres in three countries, the model also flagged 52.5% of precancerous lesions at 98.5% specificity.Healthcare
15 SepAMA adds 10 AI codes to CPT 2027 set, taking AI-related CPT codes to 43The CPT Editorial Panel also revised its Appendix S taxonomy of assistive, augmentative and autonomous AI in May 2026, ahead of the 1 January 2027 effective date.Policy

August 2026

May 2026

7 MayFDA clears Artera's AI breast cancer prognosis tool after 1,271-patient validationThe software reads H&E slides plus age, tumour size and nodal status to sort early HR+/HER2- patients into low and high risk groups for distant metastasis.Healthcare